Autophagy: Dual Response in the Development of Hepatocellular Carcinoma

Xie, 2007, Autophagosome formation: Core machinery and adaptations, Nat. Cell Biol., 9, 1102, 10.1038/ncb1007-1102

Devenish, 2012, Autophagy: Mechanism and physiological relevance “brewed” from yeast studies, Front. Biosci., 54, 1354, 10.2741/s337

White, 2015, The role for autophagy in cancer, J. Clin. Investig., 125, 42, 10.1172/JCI73941

Mizushima, 2011, Autophagy: Renovation of Cells and Tissues, Cell, 147, 728, 10.1016/j.cell.2011.10.026

Huang, 2007, Autophagy and human disease, Cell Cycle, 6, 1837, 10.4161/cc.6.15.4511

Yorimitsu, 2005, Autophagy: Molecular machinery for self-eating, Cell Death Differ., 12, 1542, 10.1038/sj.cdd.4401765

Kwanten, 2014, Role of autophagy in the pathophysiology of nonalcoholic fatty liver disease: A controversial issue, World J. Gastroenterol., 20, 7325, 10.3748/wjg.v20.i23.7325

Cui, 2013, The role of autophagy in liver cancer: Molecular mechanisms and potential therapeutic targets, Biochim. Biophys. Acta Rev. Cancer, 1836, 15, 10.1016/j.bbcan.2013.02.003

Portolani, 2006, Early and Late Recurrence after Liver Resection for Hepatocellular Carcinoma, Ann. Surg., 243, 229, 10.1097/01.sla.0000197706.21803.a1

White, 2012, Deconvoluting the context-dependent role for autophagy in cancer, Nat. Rev. Cancer, 12, 401, 10.1038/nrc3262

Janku, 2011, Autophagy as a target for anticancer therapy, Nat. Rev. Clin. Oncol., 8, 528, 10.1038/nrclinonc.2011.71

Komatsu, 2005, Impairment of starvation-induced and constitutive autophagy in Atg7-deficient mice, J. Cell Biol., 169, 425, 10.1083/jcb.200412022

Ding, 2010, Role of autophagy in liver physiology and pathophysiology, World J. Biol. Chem., 1, 3, 10.4331/wjbc.v1.i1.3

Takamura, 2011, Autophagy-deficient mice develop multiple liver tumors, Genes Dev., 25, 795, 10.1101/gad.2016211

Malhi, 2008, Cellular and Molecular Mechanisms of Liver Injury, Gastroenterology, 134, 1641, 10.1053/j.gastro.2008.03.002

Ueno, 2017, Autophagy in the liver: Functions in health and disease, Nat. Rev. Gastroenterol. Hepatol., 14, 170, 10.1038/nrgastro.2016.185

Rautou, 2010, Autophagy in liver diseases, J. Hepatol., 53, 1123, 10.1016/j.jhep.2010.07.006

Wang, 2014, Autophagy: A novel therapeutic target for hepatocarcinoma (Review), Oncol. Lett., 7, 1345, 10.3892/ol.2014.1916

Abdoli, 2018, Autophagy: The multi-purpose bridge in viral infections and host cells, Rev. Med. Virol., 28, e1973, 10.1002/rmv.1973

Singh, 2009, Autophagy regulates lipid metabolism, Nature, 458, 1131, 10.1038/nature07976

Xu, 2013, Ketogenic essential amino acids replacement diet ameliorated hepatosteatosis with altering autophagy-associated molecules, Biochim. Biophys. Acta Mol. Basis Dis., 1832, 1605, 10.1016/j.bbadis.2013.05.003

Siegel, 2017, Cancer statistics, 2017, CA Cancer J. Clin., 67, 7, 10.3322/caac.21387

Auld, 2010, Genetic variation in the cellular response of Daphnia magna (Crustacea: Cladocera) to its bacterial parasite, Proc. Biol. Sci., 277, 3291

Zhong, 2017, Prognostic role of systemic immune-inflammation index in solid tumors: A systematic review and meta-analysis, Oncotarget, 8, 75381, 10.18632/oncotarget.18856

Arzumanyan, 2013, Pathogenic mechanisms in HBV- and HCV-associated hepatocellular carcinoma, Nat. Rev. Cancer, 13, 123, 10.1038/nrc3449

Zhang, 2014, Xenophagy in Helicobacter pylori- and Epstein-Barr virus-induced gastric cancer, J. Pathol., 233, 103, 10.1002/path.4351

Shibutani, 2015, Autophagy and autophagy-related proteins in the immune system, Nat. Immunol., 16, 1014, 10.1038/ni.3273

Saitoh, 2008, Loss of the autophagy protein Atg16L1 enhances endotoxin-induced IL-1β production, Nature, 456, 264, 10.1038/nature07383

Zhou, 2011, A role for mitochondria in NLRP3 inflammasome activation, Nature, 469, 221, 10.1038/nature09663

Bujak, 2015, AMPK activation of muscle autophagy prevents fasting-induced hypoglycemia and myopathy during aging, Cell Metab., 21, 883, 10.1016/j.cmet.2015.05.016

Zhong, 2016, Autophagy, Inflammation, and Immunity: A Troika Governing Cancer and Its Treatment, Cell, 166, 288, 10.1016/j.cell.2016.05.051

Mridha, 2017, NLRP3 inflammasome blockade reduces liver inflammation and fibrosis in experimental NASH in mice, J. Hepatol., 66, 1037, 10.1016/j.jhep.2017.01.022

Petrasek, 2012, IL-1 receptor antagonist ameliorates inflammasome-dependent alcoholic steatohepatitis in mice, J. Clin. Investig., 122, 3476, 10.1172/JCI60777

Nakahira, 2011, Autophagy proteins regulate innate immune responses by inhibiting the release of mitochondrial DNA mediated by the NALP3 inflammasome, Nat. Immunol., 12, 222, 10.1038/ni.1980

Wang, 2019, CXCL17 promotes cell metastasis and inhibits autophagy via the LKB1-AMPK pathway in hepatocellular carcinoma, Gene, 690, 129, 10.1016/j.gene.2018.12.043

Kotsafti, A., Farinati, F., Cardin, R., Cillo, U., Nitti, D., and Bortolami, M. (2012). Autophagy and apoptosis-related genes in chronic liver disease and hepatocellular carcinoma. BMC Gastroenterol., 12.

Yue, 2003, Beclin 1, an autophagy gene essential for early embryonic development, is a haploinsufficient tumor suppressor, Proc. Natl. Acad. Sci. USA, 100, 15077, 10.1073/pnas.2436255100

Wu, 2016, ADRB2 signaling promotes HCC progression and sorafenib resistance by inhibiting autophagic degradation of HIF1α, J. Hepatol., 65, 314, 10.1016/j.jhep.2016.04.019

Pursiheimo, 2009, Hypoxia-activated autophagy accelerates degradation of SQSTM1/p62, Oncogene, 28, 334, 10.1038/onc.2008.392

Komatsu, 2007, Homeostatic Levels of p62 Control Cytoplasmic Inclusion Body Formation in Autophagy-Deficient Mice, Cell, 131, 1149, 10.1016/j.cell.2007.10.035

Yoshii, S.R., and Mizushima, N. (2017). Monitoring and Measuring Autophagy. Int. J. Mol. Sci., 18.

Kessler, 2015, IMP2/p62 induces genomic instability and an aggressive hepatocellular carcinoma phenotype, Cell Death Dis., 6, e1894, 10.1038/cddis.2015.241

Umemura, 2016, p62, Upregulated during Preneoplasia, Induces Hepatocellular Carcinogenesis by Maintaining Survival of Stressed HCC-Initiating Cells, Cancer Cell, 29, 935, 10.1016/j.ccell.2016.04.006

Aigelsreiter, 2017, Hepatocellular carcinomas with intracellular hyaline bodies have a poor prognosis, Liver Int., 37, 600, 10.1111/liv.13325

Moscat, 2009, p62 at the Crossroads of Autophagy, Apoptosis, and Cancer, Cell, 137, 1001, 10.1016/j.cell.2009.05.023

Zhang, H., Zhang, Y., Zhu, X., Chen, C., Zhang, C., Xia, Y., Zhao, Y., Andrisani, O., and Kong, L. (2018). DEAD Box Protein 5 Inhibits Liver Tumorigenesis by Stimulating Autophagy via Interaction with p62/SQSTM1. Hepatology.

Nicol, 2013, The RNA helicase p68 (DDX5) is selectively required for the induction of p53-dependent p21 expression and cell-cycle arrest after DNA damage, Oncogene, 32, 3461, 10.1038/onc.2012.426

Li, 2012, Interferon-gamma induces autophagy with growth inhibition and cell death in human hepatocellular carcinoma (HCC) cells through interferon-regulatory factor-1 (IRF-1), Cancer Lett., 314, 213, 10.1016/j.canlet.2011.09.031

Zhu, 2009, Regulation of autophagy by a beclin 1-targeted microRNA, miR-30a, in cancer cells, Autophagy, 5, 816, 10.4161/auto.9064

Frankel, 2011, microRNA-101 is a potent inhibitor of autophagy, EMBO J., 30, 4628, 10.1038/emboj.2011.331

Chang, 2012, MiR-375 inhibits autophagy and reduces viability of hepatocellular carcinoma cells under hypoxic conditions, Gastroenterology, 143, 177, 10.1053/j.gastro.2012.04.009

Wang, 2017, Inhibition of autophagy potentiates the proliferation inhibition activity of microRNA-7 in human hepatocellular carcinoma cells, Oncol. Lett., 14, 3566, 10.3892/ol.2017.6573

Zhou, 2017, MicroRNA-185 induces potent autophagy via AKT signaling in hepatocellular carcinoma, Tumour Biol., 39, 1010428317694313, 10.1177/1010428317694313

Chang, 2012, Manipulation of autophagy by MIR375 generates antitumor effects in liver cancer, Autophagy, 8, 1833, 10.4161/auto.21796

Wong, 2014, The impact of hypoxia in hepatocellular carcinoma metastasis, Front. Med., 8, 33, 10.1007/s11684-013-0301-3

Wilson, 2014, Hypoxia inducible factors in liver disease and hepatocellular carcinoma: Current understanding and future directions, J. Hepatol., 61, 1397, 10.1016/j.jhep.2014.08.025

Eales, 2016, Hypoxia and metabolic adaptation of cancer cells, Oncogenesis, 61, 1397

Tohme, 2017, Hypoxia mediates mitochondrial biogenesis in hepatocellular carcinoma to promote tumor growth through HMGB1 and TLR9 interaction, Hepatology, 66, 182, 10.1002/hep.29184

Schito, 2018, Cell-Autonomous Metabolic Reprogramming in Hypoxia, Trends Cell Biol., 28, 128, 10.1016/j.tcb.2017.10.006

Bellot, 2009, Hypoxia-Induced Autophagy Is Mediated through Hypoxia-Inducible Factor Induction of BNIP3 and BNIP3L via Their BH3 Domains, Mol. Cell. Biol., 29, 2570, 10.1128/MCB.00166-09

Sijtsema, 1977, Sport voor mensen met een handicap, Tijdschrift voor Ziekenverpleging, 30, 115

Peng, 2016, Egr-1 promotes hypoxia-induced autophagy to enhance chemo-resistance of hepatocellular carcinoma cells, Exp. Cell Res., 340, 62, 10.1016/j.yexcr.2015.12.006

Bjelland, 2003, Mutagenicity, toxicity and repair of DNA base damage induced by oxidation, Mutat. Res., 531, 37, 10.1016/j.mrfmmm.2003.07.002

Elazar, 2007, ROS, mitochondria and the regulation of autophagy, Trends Cell Biol., 17, 422, 10.1016/j.tcb.2007.07.009

Han, 2001, Mitochondrial respiratory chain-dependent generation of superoxide anion and its release into the intermembrane space, Biochem. J., 353, 411, 10.1042/bj3530411

Muller, 2000, The nature and mechanism of superoxide production by the electron transport chain: Its relevance to aging, Age, 23, 227, 10.1007/s11357-000-0022-9

Jain, 2010, p62/SQSTM1 is a target gene for transcription factor NRF2 and creates a positive feedback loop by inducing antioxidant response element-driven gene transcription, J. Biol. Chem., 285, 22576, 10.1074/jbc.M110.118976

Copple, 2010, Physical and functional interaction of sequestosome 1 with Keap1 regulates the Keap1-Nrf2 cell defense pathway, J. Biol. Chem., 285, 16782, 10.1074/jbc.M109.096545

Katsuragi, 2016, Regulation of the Keap1–Nrf2 pathway by p62/SQSTM1, Curr. Opin. Toxicol., 1, 54, 10.1016/j.cotox.2016.09.005

Bartolini, 2018, Nrf2-p62 autophagy pathway and its response to oxidative stress in hepatocellular carcinoma, Transl. Res., 193, 54, 10.1016/j.trsl.2017.11.007

Chen, 2016, Clinical implication of Keap1 and phosphorylated Nrf2 expression in hepatocellular carcinoma, Cancer Med., 5, 2678, 10.1002/cam4.788

Lemasters, 2005, Selective Mitochondrial Autophagy, or Mitophagy, as a Targeted Defense against Oxidative Stress, Mitochondrial Dysfunction, and Aging, Rejuv. Res., 8, 3, 10.1089/rej.2005.8.3

Wild, 2010, Mitochondria get a Parkin’ ticket, Nat. Cell Biol., 12, 104, 10.1038/ncb0210-104

Bedard, 2007, The NOX Family of ROS-Generating NADPH Oxidases: Physiology and Pathophysiology, Physiol. Rev., 87, 245, 10.1152/physrev.00044.2005

Lambeth, 2004, NOX enzymes and the biology of reactive oxygen, Nat. Rev. Immunol., 4, 181, 10.1038/nri1312

Ma, 2013, Role of Nrf2 in Oxidative Stress and Toxicity, Annu. Rev. Pharmacol. Toxicol., 53, 401, 10.1146/annurev-pharmtox-011112-140320

Twig, 2008, Fission and selective fusion govern mitochondrial segregation and elimination by autophagy, EMBO J., 27, 433, 10.1038/sj.emboj.7601963

Liu, 2017, Mitophagy Controls the Activities of Tumor Suppressor p53 to Regulate Hepatic Cancer Stem Cells, Mol. Cell, 68, 281, 10.1016/j.molcel.2017.09.022

Shi, 2018, Yap promotes hepatocellular carcinoma metastasis and mobilization via governing cofilin/F-actin/lamellipodium axis by regulation of JNK/Bnip3/SERCA/CaMKII pathways, Redox Biol., 14, 59, 10.1016/j.redox.2017.08.013

Inbal, 2002, DAP kinase and DRP-1 mediate membrane blebbing and the formation of autophagic vesicles during programmed cell death, J. Cell Biol., 157, 455, 10.1083/jcb.200109094

Dasari, 2017, Signalome-wide RNAi screen identifies GBA1 as a positive mediator of autophagic cell death, Cell Death Differ., 24, 1288, 10.1038/cdd.2017.80

Shimizu, 2010, Involvement of JNK in the regulation of autophagic cell death, Oncogene, 29, 2070, 10.1038/onc.2009.487

Arakawa, 2017, Role of Atg5-dependent cell death in the embryonic development of Bax/Bak double-knockout mice, Cell Death Differ., 24, 1598, 10.1038/cdd.2017.84

Reef, 2006, A short mitochondrial form of p19ARF induces autophagy and caspase-independent cell death, Mol. Cell, 22, 463, 10.1016/j.molcel.2006.04.014

Yanagisawa, 2003, HSpin1, a transmembrane protein interacting with Bcl-2/Bcl-xL, induces a caspase-independent autophagic cell death, Cell Death Differ., 10, 798, 10.1038/sj.cdd.4401246

Chen, 2015, High-mobility group box 1 promotes hepatocellular carcinoma progression through MIR-21-mediated matrix metalloproteinase activity, Cancer Res., 75, 1645, 10.1158/0008-5472.CAN-14-2147

Huang, 2014, Hepatocyte-specific high-mobility group box 1 deletion worsens the injury in liver ischemia/reperfusion: A role for intracellular high-mobility group box 1 in cellular protection, Hepatology, 59, 1984, 10.1002/hep.26976

Pan, 2014, HMGB1-mediated autophagy promotes docetaxel resistance in human lung adenocarcinoma, Mol. Cancer, 13, 165, 10.1186/1476-4598-13-165

Zhao, 2011, HMGB1 regulates autophagy through increasing transcriptional activities of JNK and ERK in human myeloid leukemia cells, BMB Rep., 44, 601, 10.5483/BMBRep.2011.44.9.601

Liu, 2015, Hypoxia induced HMGB1 and mitochondrial DNA interactions mediate tumor growth in hepatocellular carcinoma through Toll-like receptor 9, J. Hepatol., 63, 114, 10.1016/j.jhep.2015.02.009

Debnath, 2008, Detachment-induced autophagy during anoikis and lumen formation in epithelial acini, Autophagy, 4, 351, 10.4161/auto.5523

Peng, Y.-F., Shi, Y.-H., Shen, Y.-H., Ding, Z.-B., Ke, A.-W., Zhou, J., Qiu, S.-J., and Fan, J. (2013). Promoting colonization in metastatic HCC cells by modulation of autophagy. PLoS ONE, 8.

Seyfried, 2013, On the Origin of Cancer Metastasis, Crit. Rev. Oncog., 18, 43, 10.1615/CritRevOncog.v18.i1-2.40

Salas, 2011, PERK Integrates Autophagy and Oxidative Stress Responses To Promote Survival during Extracellular Matrix Detachment, Mol. Cell. Biol., 31, 3616, 10.1128/MCB.05164-11

Sharifi, 2016, Autophagy Promotes Focal Adhesion Disassembly and Cell Motility of Metastatic Tumor Cells through the Direct Interaction of Paxillin with LC3, Cell Rep., 15, 1660, 10.1016/j.celrep.2016.04.065

Li, 2013, Autophagy promotes hepatocellular carcinoma cell invasion through activation of epithelial–mesenchymal transition, Carcinogenesis, 34, 1343, 10.1093/carcin/bgt063

Peng, 2013, Autophagy inhibition suppresses pulmonary metastasis of HCC in mice via impairing anoikis resistance and colonization of HCC cells, Autophagy, 9, 2056, 10.4161/auto.26398

Wang, 2018, Fluid shear stress promotes autophagy in hepatocellular carcinoma cells, Int. J. Biol. Sci., 14, 1277, 10.7150/ijbs.27055

Shen, 2011, Autophagic cell death: Loch Ness monster or endangered species?, Autophagy, 7, 457, 10.4161/auto.7.5.14226

Boya, 2005, Inhibition of Macroautophagy Triggers Apoptosis, Mol. Cell. Biol., 25, 1025, 10.1128/MCB.25.3.1025-1040.2005

Cheng, 2009, Efficacy and safety of sorafenib in patients in the Asia-Pacific region with advanced hepatocellular carcinoma: A phase III randomised, double-blind, placebo-controlled trial, Lancet Oncol., 10, 25, 10.1016/S1470-2045(08)70285-7

Fouad, 2014, Sorafenib-based combination as a first line treatment for advanced hepatocellular carcinoma: A systematic review of the literature, Crit. Rev. Oncol. Hematol., 91, 1, 10.1016/j.critrevonc.2013.12.013

Decaens, 2012, Phase II study of sirolimus in treatment-naive patients with advanced hepatocellular carcinoma, Dig. Liver Dis., 44, 610, 10.1016/j.dld.2012.02.005

Adnane, 2006, Sorafenib (BAY 43-9006, Nexavar®), a Dual-Action Inhibitor That Targets RAF/MEK/ERK Pathway in Tumor Cells and Tyrosine Kinases VEGFR/PDGFR in Tumor Vasculature, Methods Enzymol., 407, 597, 10.1016/S0076-6879(05)07047-3

Shimizu, 2012, Inhibition of autophagy potentiates the antitumor effect of the multikinase inhibitor sorafenib in hepatocellular carcinoma, Int. J. Cancer, 131, 548, 10.1002/ijc.26374

Gedaly, 2012, PKI-587 and sorafenib targeting PI3K/AKT/mTOR and Ras/Raf/MAPK pathways synergistically inhibit HCC cell proliferation, J. Surg. Res., 176, 542, 10.1016/j.jss.2011.10.045

Gallego, 2019, Molecular characterization of autophagic and apoptotic signaling induced by sorafenib in liver cancer cells, J. Cell. Physiol., 234, 692, 10.1002/jcp.26855

Nishida, 2015, Molecular Mechanism and Prediction of Sorafenib Chemoresistance in Human Hepatocellular Carcinoma, Dig. Dis., 33, 771, 10.1159/000439102

Lachenmayer, 2012, Combination therapy for hepatocellular carcinoma: Additive preclinical efficacy of the HDAC inhibitor panobinostat with sorafenib, J. Hepatol., 56, 1343, 10.1016/j.jhep.2012.01.009

Liang, 2013, Hypoxia-mediated sorafenib resistance can be overcome by EF24 through Von Hippel-Lindau tumor suppressor-dependent HIF-1α inhibition in hepatocellular carcinoma, Hepatology, 57, 1847, 10.1002/hep.26224

Fondevila, 2017, Melatonin enhances sorafenib actions in human hepatocarcinoma cells by inhibiting mTORC1/p70S6K/HIF-1α and hypoxia-mediated mitophagy, Oncotarget, 8, 91402, 10.18632/oncotarget.20592

Mauriz, 2016, Modulation of Autophagy by Sorafenib: Effects on Treatment Response, Front. Pharmacol., 7, 151

Zhi, 2015, Autophagy in cancer, F1000Prime Rep., 7, 18, 10.12703/P7-18

Ding, 2011, Autophagy Activation in Hepatocellular Carcinoma Contributes to the Tolerance of Oxaliplatin via Reactive Oxygen Species Modulation, Clin. Cancer Res., 17, 6229, 10.1158/1078-0432.CCR-11-0816

Sheng, 2018, Targeting autophagy in chemotherapy-resistant of hepatocellular carcinoma, Am. J. Cancer Res., 8, 354

Toshima, 2014, Autophagy enhances hepatocellular carcinoma progression by activation of mitochondrial β-oxidation, J. Gastroenterol., 49, 907, 10.1007/s00535-013-0835-9

Hu, 2018, Autophagy suppresses proliferation of HepG2 cells via inhibiting glypican-3/wnt/β-catenin signaling, Oncotargets Ther., 11, 193, 10.2147/OTT.S150520

Krause, 2016, Rapamycin and fructose-1,6-bisphosphate reduce the HEPG2 cell proliferation via increase of free radicals and apoptosis, Oncol. Rep., 36, 2647, 10.3892/or.2016.5111

Engl, 2017, mTOR inhibition reduces growth and adhesion of hepatocellular carcinoma cells in vitro, Mol. Med. Rep., 16, 7064, 10.3892/mmr.2017.7401

Kim, 2017, Potentiation of the anticancer effects of everolimus using a dual mTORC1/2 inhibitor in hepatocellular carcinoma cells, Oncotarget, 8, 2936, 10.18632/oncotarget.13808

Tong, 2015, Inhibition of MEK/ERK activation attenuates autophagy and potentiates pemetrexed-induced activity against HepG2 hepatocellular carcinoma cells, Biochem. Biophys. Res. Commun., 456, 86, 10.1016/j.bbrc.2014.11.038

Huang, 2014, A sorafenib derivative and novel SHP-1 agonist, SC-59, acts synergistically with radiotherapy in hepatocellular carcinoma cells through inhibition of STAT3, Cancer Lett., 349, 136, 10.1016/j.canlet.2014.04.006

Tai, 2013, Mcl-1-dependent activation of Beclin 1 mediates autophagic cell death induced by sorafenib and SC-59 in hepatocellular carcinoma cells, Cell Death Dis., 4, e485, 10.1038/cddis.2013.18

Chang, 2013, Dual PI3K/mTOR inhibitor NVP-BEZ235-induced apoptosis of hepatocellular carcinoma cell lines is enhanced by inhibitors of autophagy, Int. J. Mol. Med., 31, 1449, 10.3892/ijmm.2013.1351

Simioni, 2013, The AKT Inhibitor MK-2206 is Cytotoxic in Hepatocarcinoma Cells Displaying Hyperphosphorylated AKT-1 and Synergizes with Conventional Chemotherapy, Oncotarget, 4, 1496, 10.18632/oncotarget.1236

Zhang, 2012, Induction of autophagy in hepatocellular carcinoma cells by SB203580 requires activation of AMPK and DAPK but not p38 MAPK, Apoptosis, 17, 325, 10.1007/s10495-011-0685-y

Refolo, 2013, Reversibility of regorafenib effects in hepatocellular carcinoma cells, Cancer Chemother. Pharmacol., 72, 869, 10.1007/s00280-013-2269-8

Yu, 2013, Nilotinib induces autophagy in hepatocellular carcinoma through AMPK activation, J. Biol. Chem., 288, 18249, 10.1074/jbc.M112.446385

Ni, 2014, HCC cells with high levels of Bcl-2 are resistant to ABT-737 via activation of the ROS-JNK-autophagy pathway, Free Radic. Biol. Med., 70, 194, 10.1016/j.freeradbiomed.2014.02.012

Gao, 2008, OSU-03012, a novel celecoxib derivative, induces reactive oxygen species-related autophagy in hepatocellular carcinoma, Cancer Res., 68, 9348, 10.1158/0008-5472.CAN-08-1642

Saeki, 2013, Bortezomib induces tumor-specific cell death and growth inhibition in hepatocellular carcinoma and improves liver fibrosis, J. Gastroenterol., 48, 738, 10.1007/s00535-012-0675-z

Du, 2012, Role of autophagy in resistance to oxaliplatin in hepatocellular carcinoma cells, Oncol. Rep., 27, 143

Chen, 2011, Autophagy inhibition enhances apoptosis triggered by BO-1051, an N-mustard derivative, and involves the ATM signaling pathway, Biochem. Pharmacol., 81, 594, 10.1016/j.bcp.2010.12.011

Hou, 2011, Inhibition of active autophagy induces apoptosis and increases chemosensitivity in cholangiocarcinoma, Lab. Invest., 91, 1146, 10.1038/labinvest.2011.97

Rong, 2017, Combination of wogonin and sorafenib effectively kills human hepatocellular carcinoma cells through apoptosis potentiation and autophagy inhibition, Oncol. Lett., 13, 5028, 10.3892/ol.2017.6059

Yan, 2016, Bafilomycin A1 induces caspase-independent cell death in hepatocellular carcinoma cells via targeting of autophagy and MAPK pathways, Sci. Rep., 6, 37052, 10.1038/srep37052

Thoen, 2011, A role for autophagy during hepatic stellate cell activation, J. Hepatol., 55, 1353, 10.1016/j.jhep.2011.07.010

Bialik, 2009, Life and death partners: Apoptosis, autophagy and the cross-talk between them, Cell Death Differ., 16, 966, 10.1038/cdd.2009.33

Booth, 2014, The role of cell signalling in the crosstalk between autophagy and apoptosis, Cell. Signal., 26, 549, 10.1016/j.cellsig.2013.11.028

McFarlane, 2011, Interaction of the human cytomegalovirus particle with the host cell induces hypoxia-inducible factor 1 alpha, Virology, 414, 83, 10.1016/j.virol.2011.03.005